These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2382295)

  • 21. Immunologic phenotype of hosts orally immunized with corneal alloantigens.
    Ma D; Li XY; Mellon J; Niederkorn JY
    Invest Ophthalmol Vis Sci; 1998 Apr; 39(5):744-53. PubMed ID: 9538881
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ICAM-1 deficiency suppresses host allosensitization and rejection of MHC-disparate corneal transplants.
    Zhu SN; Yamada J; Streilein JW; Dana MR
    Transplantation; 2000 Mar; 69(5):1008-13. PubMed ID: 10755569
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fate of orthotopic corneal allografts in eyes that cannot support anterior chamber-associated immune deviation induction.
    Sano Y; Ksander BR; Streilein JW
    Invest Ophthalmol Vis Sci; 1995 Oct; 36(11):2176-85. PubMed ID: 7558710
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of donor-specific cytotoxic T cells in rejection of corneal allografts in normal and high-risk eyes.
    Ksander BR; Sano Y; Streilein JW
    Transpl Immunol; 1996 Mar; 4(1):49-52. PubMed ID: 8762010
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of CD4+ T cells in immunobiology of orthotopic corneal transplants in mice.
    Yamada J; Kurimoto I; Streilein JW
    Invest Ophthalmol Vis Sci; 1999 Oct; 40(11):2614-21. PubMed ID: 10509657
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of local macrophage depletion on cellular immunity and tolerance evoked by corneal allografts.
    Slegers TP; van der Gaag R; van Rooijen N; van Rij G; Streilein JW
    Curr Eye Res; 2003 Feb; 26(2):73-9. PubMed ID: 12815525
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interleukin 1 receptor antagonist suppresses allosensitization in corneal transplantation.
    Yamada J; Dana MR; Zhu SN; Alard P; Streilein JW
    Arch Ophthalmol; 1998 Oct; 116(10):1351-7. PubMed ID: 9790635
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of LFA-1 and ICAM-1 antibody treatment on murine corneal allograft survival.
    He Y; Mellon J; Apte R; Niederkorn JY
    Invest Ophthalmol Vis Sci; 1994 Jul; 35(8):3218-25. PubMed ID: 7913917
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The immunogenic privilege of corneal allografts.
    Niederkorn JY; Peeler JS; Ross J; Callanan D
    Reg Immunol; 1989; 2(2):117-24. PubMed ID: 2701814
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD4+ T cells are critical for corneal, but not skin, allograft rejection.
    Haskova Z; Usiu N; Pepose JS; Ferguson TA; Stuart PM
    Transplantation; 2000 Feb; 69(4):483-7. PubMed ID: 10708099
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunobiology of xenogeneic cornea grafts in mouse eyes. II. Immunogenicity of xenogeneic cornea tissue grafts implanted in anterior chamber of mouse eyes.
    Tanaka K; Streilein JW
    Transplantation; 2000 Feb; 69(4):616-23. PubMed ID: 10708120
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of Langerhans' cells on cytotoxic T lymphocyte responses to major and minor alloantigens expressed on heterotopic corneal allografts.
    Peeler JS; Niederkorn JY
    Transplant Proc; 1987 Feb; 19(1 Pt 1):316-9. PubMed ID: 3547821
    [No Abstract]   [Full Text] [Related]  

  • 33. Immunologic mechanisms of corneal allografts reconstituted from cultured allogeneic endothelial cells in an immune-privileged site.
    Hayashi T; Yamagami S; Tanaka K; Yokoo S; Usui T; Amano S; Mizuki N
    Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3151-8. PubMed ID: 19255161
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [CTLA4-Ig prevents corneal allograft rejection in mice].
    Shi WY; Xie LX
    Zhonghua Yan Ke Za Zhi; 2004 Oct; 40(10):696-700. PubMed ID: 16200862
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of anti-skin allograft immunity induced by infusions with photoinactivated effector T lymphocytes--the congenic model.
    Perez MI; Berger CL; Yamane Y; John L; Laroche L; Edelson RL
    Transplantation; 1991 Jun; 51(6):1283-9. PubMed ID: 1828639
    [TBL] [Abstract][Full Text] [Related]  

  • 36. On the Ia immunogenicity of mouse corneal allografts infiltrated with Langerhans cells.
    Rubsamen PE; McCulley J; Bergstresser PR; Streilein JW
    Invest Ophthalmol Vis Sci; 1984 May; 25(5):513-8. PubMed ID: 6370903
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of primed donor-specific T cells in recipient mice bearing orthotopic corneal allografts.
    Sano Y; Ksander BR; Streilein JW
    Transplantation; 2000 Nov; 70(9):1302-10. PubMed ID: 11087144
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induction of allograft tolerance to the H-Y antigen in adult C57BL/6 mice: differential effects on delayed-type hypersensitivity and cytolytic T-lymphocyte activity.
    Busker AE; Miller SD; Melvold RW
    Cell Immunol; 1990 Jan; 125(1):225-34. PubMed ID: 2293899
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Histopathology of rejected orthotopic corneal grafts in the rat.
    Callanan DG; Luckenbach MW; Fischer BJ; Peeler JS; Niederkorn JY
    Invest Ophthalmol Vis Sci; 1989 Mar; 30(3):413-24. PubMed ID: 2647659
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Presentation of the H-Y antigen on Langerhans' cell-negative corneal grafts downregulates the cytotoxic T cell response and converts responder strain mice into phenotypic nonresponders.
    Peeler JS; Callanan DG; Luckenbach MW; Niederkorn JY
    J Exp Med; 1988 Nov; 168(5):1749-66. PubMed ID: 2972795
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.